α-synuclein (αSyn) undergoes aggregation and is thought to contribute to disease pathogenesis in several neurodegenerative diseases (i.e. PD, Lewy body dementia [LBD], multiple system atrophy [MSA]), collectively termed α-synucleinopathies1,2. Here, SNCA is linked to Parkinson disease.